Evidence map›Paper›PMID 36071684›Full record

ArticleCell cycle (Georgetown, Tex.)2023

LncRNA FGF7-5 and lncRNA GLRX3 together inhibits the formation of carotid plaque via regulating the miR-2681-5p/ERCC4 axis in atherosclerosis.

Jian-Jin Wu, Jie Jin, Yong-Hua Li, Chao Wang, Jun Bai, Qing-Jun Jiang, Tian-Xiao He, Shao-Jie Nie, Dong-Jie Li, Le-Feng Qu

Open access · greenAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Noncoding RNAs as Key Regulators for Cardiac Development and Cardiovascular Diseases.Journal of cardiovascular development and disease · 2023
    Review
  8. LINC01088 Targets miR-195-5p to Promote Proliferation and Migration and Reduce Apoptosis in the Inhibition of Carotid Artery Stenosis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jian-Jin WuDepartment of Vascular and Endovascular Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Jie JinDepartment of Vascular and Endovascular Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Yong-Hua LiDepartment of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Chao WangDepartment of Vascular and Endovascular Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Jun BaiDepartment of Vascular and Endovascular Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Qing-Jun JiangDepartment of Vascular and Endovascular Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Tian-Xiao HeDepartment of Vascular and Endovascular Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Shao-Jie NieDepartment of Vascular and Endovascular Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Dong-Jie LiDepartment of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Le-Feng QuDepartment of Vascular and Endovascular Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Second Military Medical University · CNShanghai Changzheng Hospital · CNShanghai Tenth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerotic plaques belong to the common vascular disease in the aged, which rupture will lead to acute thromboembolic diseases, the leading cause of fatal cardiovascular events. Accumulating evidence indicates that the lncRNAs-miRNAs-mRNA regulatory network plays a critical role in atherosclerosis. Based on RNA sequencing (GSE207252), we constructed expression profiles of lncRNAs, microRNAs, and mRNA in the carotid plaque of atherosclerosis patients and analyzed differentially expressed genes (DEGs). We identified three candidate lncRNAs using two algorithms (LASSO and SVM-RFE): lnc_GLRX3, lnc_FGF7-5, and DISC1FP1). LNCipedia, TargetScan, and miRDB databases were used to predict target miRNAs of lncRNAs and target genes of miRNAs. Gene ontology (GO) functional annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Gene Set Enrichment Analysis (GSEA) analysis of DEGs was carried out using the R package clusterProfiler. A PPI network was constructed using the STRING website and visualized by Cytoscape. According to the "MCC" method of the plug-in cytoHubba in Cytoscape, ERCC4 was the top hub gene of the PPI network. We constructed a lncRNA_FGF7-5/lncRNA_GLRX3-miR-2681-5p-ERCC4 regulatory network for carotid plaque using lncRNA-miRNA and miRNA-mRNA pairs. Next, lncRNA_FGF7-5 and lncRNA_GLRX3 targeted miR-2681-5p directly to upregulate ERCC4 expression. Silencing of lncRNA_FGF7-5 and lncRNA_GLRX3 promoted apoptosis and TP53 expression in HUVECs treated with ox-LDL; however, these effects were reversed by ERCC4-overexpression. Taken together, these findings indicated that lncRNA_FGF7-5 and lncRNA_GLRX3 together reduced atherosclerosis-induced apoptosis of HUVECs via targeting miR-2681-5p to increase ERCC4 expression, thereby preventing the formation of carotid plaque and finally inhibiting atherosclerosis progression.

Indexed as

AtherosclerosisMicroRNAsPlaque, AtheroscleroticRNA, Long NoncodingAgedCarrier ProteinsFibroblast Growth Factor 7Gene Regulatory NetworksHumansRNA, MessengerCarrier ProteinsFGF7 protein, humanFibroblast Growth Factor 7GLRX3 protein, humanMicroRNAsRNA, Long NoncodingRNA, MessengeratherosclerosisLncRNA FGF7-5lncRNA GLRX3

Identifiers

PMID36071684
PMCPMC9815221
OpenAlexW4294934796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.